These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 15942893

  • 1. Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
    Rouzioux C, Hubert JB, Burgard M, Deveau C, Goujard C, Bary M, Séréni D, Viard JP, Delfraissy JF, Meyer L, SEROCO Cohort Study Group.
    J Infect Dis; 2005 Jul 01; 192(1):46-55. PubMed ID: 15942893
    [Abstract] [Full Text] [Related]

  • 2. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C, Bonarek M, Meyer L, Bonnet F, Chaix ML, Deveau C, Sinet M, Galimand J, Delfraissy JF, Venet A, Rouzioux C, Morlat P, Agence Nationale de Recherche sur le Sida PRIMO Study Group.
    Clin Infect Dis; 2006 Mar 01; 42(5):709-15. PubMed ID: 16447119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD.
    N Engl J Med; 1996 Feb 15; 334(7):426-31. PubMed ID: 8552144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ.
    Arch Intern Med; 2006 Jan 09; 166(1):64-70. PubMed ID: 16401812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Despite being highly diverse, immunovirological status strongly correlates with clinical symptoms during primary HIV-1 infection: a cross-sectional study based on 674 patients enrolled in the ANRS CO 06 PRIMO cohort.
    Ghosn J, Deveau C, Chaix ML, Goujard C, Galimand J, Zitoun Y, Allègre T, Delfraissy JF, Meyer L, Rouzioux C, ANRS PRIMO Cohort.
    J Antimicrob Chemother; 2010 Apr 09; 65(4):741-8. PubMed ID: 20167586
    [Abstract] [Full Text] [Related]

  • 9. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M, Smith DM, Liu L, May S, Tenorio AR, Ignacio CC, Landay A, Haubrich R.
    J Infect Dis; 2006 Jul 01; 194(1):29-37. PubMed ID: 16741879
    [Abstract] [Full Text] [Related]

  • 10. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, Kagan J.
    Clin Infect Dis; 2005 Mar 15; 40(6):853-8. PubMed ID: 15736019
    [Abstract] [Full Text] [Related]

  • 11. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
    Pasternak AO, Jurriaans S, Bakker M, Berkhout B, Lukashov VV.
    AIDS; 2010 Jul 17; 24(11):1641-9. PubMed ID: 20543660
    [Abstract] [Full Text] [Related]

  • 12. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.
    Gupta P, Kingsley L, Armstrong J, Ding M, Cottrill M, Rinaldo C.
    Virology; 1993 Oct 17; 196(2):586-95. PubMed ID: 8103948
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of human immunodeficiency virus (HIV) type 1 load, CD4 T cell level, and clinical class as time-fixed and time-varying markers of disease progression in HIV-1-infected children.
    Kalish LA, McIntosh K, Read JS, Diaz C, Landesman SH, Pitt J, Rich KC, Shearer WT, Davenny K, Lew JF.
    J Infect Dis; 1999 Nov 17; 180(5):1514-20. PubMed ID: 10515810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD, EuroSIDA study group.
    HIV Med; 2007 Mar 17; 8(2):96-104. PubMed ID: 17352766
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D, Vitone F, Schiavone P, Ponti C, La Placa M, Re MC.
    J Clin Virol; 2004 Apr 17; 29(4):282-9. PubMed ID: 15018857
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
    Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J.
    J Infect Dis; 2002 Oct 15; 186(8):1181-5. PubMed ID: 12355373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.